Intrinsic Value

The intrinsic value of Neuronetics Inc (STIM) under the Base Case is 3.1 USD per share. Compared with the current market price of 2.24 USD, the stock appears Undervalued by 28% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

STIM Intrinsic Value
$3.1
Undervaluation 28%
Intrinsic Value
Price $2.24

STIM is valued in line with its history. A discount of this size has been typical over the past 5 years.

Monitor STIM
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $2.48
Get notified when the price drops into your buy zone
Intrinsic Value $3.1
Margin of Safety 20% $2.48
Current Price $2.24
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to STIM

Fundamental Analysis

What Neuronetics Does

Health Care

Neuronetics makes and sells the NeuroStar system, a medical device used by doctors to treat major depressive disorder and certain other mental health conditions without surgery or drugs. The company’s main customers are outpatient psychiatry clinics, hospitals, and other providers that offer brain stimulation therapy to patients who have not responded well to medication alone.

Headquarters
United States of America US
Employees
658
IPO date
Jun 28, 2018
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Neuronetics Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

STIM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one STIM stock?

The intrinsic value for Neuronetics Inc (STIM) under the Base Case is 3.1 USD.

Is STIM stock undervalued or overvalued?

Compared with the current market price of 2.24 USD, the stock appears Undervalued by 28% .

Back to Top